Global Oral Transmucosal Drugs Marketplace 2021-2031 - Market Share Analysis of Leading Companies and YoY Growth Projections with Revenue Breakdown by Segment - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Oral Transmucosal Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's offering.
This report on the global oral transmucosal drugs market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global oral transmucosal drugs market for the period of 2017-2031, considering 2020 as the base year and 2031 as the forecast year. the report also provides the compound annual growth rate (CAGR) for the global oral transmucosal drugs market during the forecast period.
The report delves into the competitive landscape of the global oral transmucosal drugs market. Key players operating in the global oral transmucosal drugs market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global oral transmucosal drugs market that have been profiled in this report.
Key Questions Answered
- What are the major drivers, restraints, and opportunities in the market?
- What will be the Y-o-Y growth of the global oral transmucosal drugs market between 2021 and 2031?
- What are the revenue share projections of key segments of the global oral transmucosal drugs market during the forecast period?
- Will North America continue to be the most profitable market for oral transmucosal drugs?
- Which factors are anticipated to restrain the global oral transmucosal drugs market during the forecast period?
- Which are the leading companies in the global oral transmucosal drugs market?
Key Topics Covered
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Oral Transmucosal Drugs Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.4. Global Oral Transmucosal Drugs Market Analysis and Forecast, 2017-2031
5. Key Insights
5.1. Key Mergers & Acquisitions
5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
5.3. Top 3 players operating in the market space
5.4. Clinical Trials & Pipeline Analysis
5.5. Oral Transmucosal Drugs Market SWOT Analysis
6. Global Oral Transmucosal Drugs Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type, 2017-2031
6.4. Market Attractiveness Analysis, by Type
7. Global Oral Transmucosal Drugs Market Analysis and Forecast, by Route of Penetration
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Route of Penetration, 2017-2031
7.4. Market Attractiveness Analysis, by Route of Penetration
8. Global Oral Transmucosal Drugs Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Distribution Channel, 2017-2031
8.4. Market Attractiveness Analysis, by Distribution Channel
9. Global Oral Transmucosal Drugs Market Analysis and Forecast, by Indication
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by Indication, 2017-2031
9.4. Market Attractiveness Analysis, by Indication
10. Global Oral Transmucosal Drugs Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.3. Market Attractiveness Analysis, by Country/Region
11. North America Oral Transmucosal Drugs Market Analysis and Forecast
12. Europe Oral Transmucosal Drugs Market Analysis and Forecast
13. Asia Pacific Oral Transmucosal Drugs Market Analysis and Forecast
14. Latin America Oral Transmucosal Drugs Market Analysis and Forecast
15. Middle East & Africa Oral Transmucosal Drugs Market Analysis and Forecast
16. Competition Landscape
16.1. Market Share Analysis, by Company, 2020
16.2. Company Profiles
16.2.1. LTS Lohmann Therapie-Systeme AG
16.2.2. Soligenix
16.2.3. ZIM Laboratories Limited
16.2.4. Access Pharmaceutical, Inc.
16.2.5. C.L Pharm
16.2.6. Seoul Pharmaceuticals
16.2.7. Cure Pharmaceutical
16.2.8. Aquestive Therapeutics, Inc.
16.2.9. Solvay S.A.
16.2.10. NAL Pharma
16.2.11. IntelGenx Corp.
16.2.12. Izun Pharmaceuticals
16.2.13. Eisai Co. Ltd.
16.2.14. AstraZeneca
16.2.15. Otsuka Pharmaceutical Co. Ltd.
16.2.16. Pfizer, Inc.
16.2.17. Teva Pharmaceutical Industries Ltd.
16.2.18. GlaxoSmithKline plc
16.2.19. Mylan N.V.
16.2.20. Bristol-Myers Squibb Company
For more information about this report visit https://www.researchandmarkets.com/r/o84lq9
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Editor Details
-
Company:
- Businesswire
